Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Anesthesiology Reports
Published in: Current Anesthesiology Reports 2/2018

01-06-2018 | Neuromuscular Blockade (GS Murphy, Section Editor)

Mivacurium: a Review

Authors: Lisa S. Molloy, Thomas Ledowski

Published in: Current Anesthesiology Reports | Issue 2/2018

Login to get access

Abstract

Purpose of Review

Mivacurium is a short-acting non-depolarizing neuromuscular-blocking agent (NMBA) which has recently been re-released onto the US market. This review provides a brief overview about the pharmacology of mivacurium and discusses its use in recent clinical practice.

Recent Findings

Mivacurium has been reported to be especially useful in the pediatric population, especially for shorter cases, and infusions can be used for longer cases without inducing tachyphylaxis. As it is rapidly metabolized by pseudocholinesterase (PChE), mivacurium does usually not require a specific reversal agent to offset its actions at the end of surgery. Especially for use in short cases, this makes it a potentially advantageous alternative to the use of other NMBA. However, deficiencies in PChE as well as old age and some drug interactions can be associated with prolonged neuromuscular blockade. The rapid administration of higher doses may provoke significant histamine release leading to hemodynamic compromise.

Summary

Despite other NMBA being available on the market and its side effects, mivacurium may still be a useful agent in short cases, particularly in the pediatric population.
Literature
1.
2.
Smith S, Scarth E, Asada M. Mivacurium In. Drugs in anaesthesia and intensive care 4th Ed. 2011 Oxford. Oxford University Press 2011 pgs 232–233.
3.
• Zeng R, Liu X, Yin N, Fei J, Zhong S, Hu Z, et al. The efficacy and safety of mivacurium in paediatric patients. BMC Anesthes Open Access. 2017;17:58. A review of the use of mivacurium in various age groups in the pediatric population. CrossRef
4.
Modolo NSM, do Nascimento Junior P, da Justa Croitor LB, PTG V, YMM C, Ganem EM, et al. Onset time and duration of rocuronium, atracurium and mivacurium in pediatric patients. Rev Bras de Anestesiol. 2002;52(2):191–6.CrossRef
5.
• Soliday FK, Conley YP, Henker R. Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired a and drug influences. AANA Jnl. 2010;78(4):313–20. This article is a comprehensive review of the genetics, drug interactions, and conditions associated with pseudocholinesterase deficiency
6.
Delacour H, Lushchekina S, Mabbox I, Ceppa F, Masson P, Schopfer LM, et al. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), “silent” with mivacurium. Biochem Pharmacol. 2014;93:476–83.CrossRef
7.
Niazi A, Leonard IE, O’Kelly B. Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency. J Clin Anes. 2004;16:40–2.CrossRef
8.
Alibhai M, Wheatley S. Mivacurium, fixation error and human factors. HSOA J Anaes Clin Care. 2017;4:20–1.
9.
Zhou W, Sheng L. Delayed recovery from paralysis associated with plasma cholinesterase deficiency. Springer Plus Open Access. 2016;5:1887.CrossRef
10.
Cassel J, Staehr-Rye AK, Nielsen CV, Gate MR. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports. Acta Anaesthesiol Scand. 2014;53:1040–3.CrossRef
11.
Han TH, Martyn JAJ. Neuromuscular pharmacodynamics of mivacurium in adults with major burns. BJA. 2011;106(5):675–9.CrossRef
12.
Martyn JAJ, Chang Y, Goudsouzian NG, Patel SS. Pharmacodynamics of mivacurium chloride in 13 - 18 year old adolescents with thermal injury. BJA. 2002;89(4):589–5.CrossRef
13.
Martyn JAJ, Goudsouzain NG, Chang YC, Szyfelbein SK, Schwartz AE, Patel SS. Neuromuscular effects of mivacurium in 2-12 year old children with burn injury. Anesthesiology. 2000;92:31–7.CrossRef
14.
Tercan M, Mercanoglu EE, Turker G, Nur Kaya F, Yavascoaglu B, Ozarda Y, et al. Do metoclopromide and onadsetrone alter mivacurium-induced neuomuscular blockade?—a randomised trial. Rev Bras Anastesiol. 2014;64:34–9.
15.
Skinner HJ, Girling KJ, Whitehurst A, Natheson MH. Influence of metoclopromide on plasma cholinesterase and duration of action of mivacurium. BJA. 1999;82:542–5.CrossRef
16.
Motomed C, Kirov K, Combes X, Dhonnev G, Duvaldestin P. Effect of metoclopromide on mivacurium induced neuromuscular block. Acta Anesthesiol Scand. 2002;46:214–6.CrossRef
17.
Zencirci B. Sertraline induced pseudocholinesterase enzyme deficiency. Int J Gen Med. 2010;3:375–8.CrossRef
18.
• Plaud B, Marty J, Debaene B, Meistelman C, Pellissier D, LePage JY, et al. The cardiovascular effects of mivacurium in hypertensive patients. Anaesth Analg. 2002;95:379–84. A study which compares hypertensive and normotensive and the effect of the rates of mivacurium boluses which is highly relevant to clinical practice.
19.
Erol D. Bronchospasm in a pediatric adenoidectomy case. Int J Anesth. 2014;11:1.
20.
Rajesh MC. Anesthesia for children with bronchial asthma and respiratory infections. Ind J Anesth. 2015;59(9):584–8.CrossRef
21.
Fine GF, Motoyama EK, Brandom BW, Fertal KM, Mutich R, Davis PJ. The effect on lung mechanics in anesthetized children with rapacuronium: a comparative study with mivacurium. Anesth Analg. 2002 Jul;95(1):56–61.CrossRef
22.
Bishop MJ, O’Donnell JT, Salemi JR. Mivacurium and bronchospasm. Anesth Analg. 2003;97:484–5.CrossRef
23.
Xiang Z, Yahiang Q, Ziao-Yang S, Yan-Hui Z, Min C, Guo Sheng G, et al. Effects of promethazine or dexamethasone on mivacurium induced histamine in children. Peds Anesth. 2014;24(3):322–6.CrossRef
24.
Nagle P, Hammerle AF. Sevoflurane and mivacurium in a patient with Huntington’s chorea. BJA. 2000;85(2):320–1.CrossRef
25.
Munster T, Schmidt HJ. Mivacurium in multicore disease. Anaesth Intensive Care. 2006;34(3):401.PubMed
26.
Sungur Ulke Z, Senturk M. Mivacurium in patients with myasthenia graves undergoing video - assisted thorascopic thymectomy. BJA. 2009;103:310–31.CrossRef
27.
Mizrak A, Bozgeyik S, Karakurum G, Kocamer B, Oner U. The addition of low dose mivacruium to lidocaine for intravenous regional anesthesia. J Musculoskeletal Pain. 2010;18(2):138–45.CrossRef
28.
Hoffmann U, Grosse-Sundrup M, Eikermann-Haerter K, Zaremba S, Ayata C, Zhang B, et al. Calabadion: a new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents. Anesthesiology. 2013 Aug;119(2):317–25.CrossRef
29.
Soto RG, Dunipace D. Mivacurium: return of a drug seeking an indication. ASA Monitor. 2017;81:30–1.
Metadata
Title
Mivacurium: a Review
Authors
Lisa S. Molloy
Thomas Ledowski
Publication date
01-06-2018
Publisher
Springer US
Published in
Current Anesthesiology Reports / Issue 2/2018
Electronic ISSN: 2167-6275
DOI
https://doi.org/10.1007/s40140-018-0264-7

Other articles of this Issue 2/2018

Current Anesthesiology Reports 2/2018 Go to the issue

Transplantation Anesthesia (KG Belani, Section Editor)

Issues in Pediatric Liver Transplantation

Neuromuscular Blockade (GS Murphy, Section Editor)

Sugammadex: Appropriate Use in the Context of Budgetary Constraints

Neuromuscular Blockade (GS Murphy, Section Editor)

Sugammadex: Clinical Pharmacokinetics and Pharmacodynamics

Neuromuscular Blockade (GS Murphy, Section Editor)

Qualitative Neuromuscular Monitoring: Patterns of Stimulation, Site of Monitoring, and Accuracy in Detecting Residual Neuromuscular Blockade

Advances in Monitoring for Anesthesia (LAH Critchley, Section Editor)

Latest Advances in Cardiac Output Monitoring from High-Definition Impedance Cardiography

Geriatric Anesthesia (S Akhtar, Section Editor)

Frailty and Perioperative Outcomes